These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11562370)

  • 21. Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.
    Hennig AK; Levy B; Ogilvie JM; Vogler CA; Galvin N; Bassnett S; Sands MS
    J Neurosci; 2003 Apr; 23(8):3302-7. PubMed ID: 12716937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
    Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
    Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer.
    Daly TM; Ohlemiller KK; Roberts MS; Vogler CA; Sands MS
    Gene Ther; 2001 Sep; 8(17):1291-8. PubMed ID: 11571565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human β-glucuronidase: structure, function, and application in enzyme replacement therapy.
    Naz H; Islam A; Waheed A; Sly WS; Ahmad F; Hassan I
    Rejuvenation Res; 2013 Oct; 16(5):352-63. PubMed ID: 23777470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
    Ross CJ; Bastedo L; Maier SA; Sands MS; Chang PL
    Hum Gene Ther; 2000 Oct; 11(15):2117-27. PubMed ID: 11044913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
    Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.
    Woloszynek JC; Roberts M; Coleman T; Vogler C; Sly W; Semenkovich CF; Sands MS
    Biochem J; 2004 Apr; 379(Pt 2):461-9. PubMed ID: 14705966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer.
    Kosuga M; Takahashi S; Sasaki K; Enosawa S; Li XK; Okuyama S; Fujino M; Suzuki S; Yamada M; Matsuo N; Sakuragawa N; Okuyama T
    Cell Transplant; 2000; 9(5):687-92. PubMed ID: 11144966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.
    Bigg PW; Sleeper MM; O'Donnell PA; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Nov; 110(3):311-8. PubMed ID: 23860311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
    Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
    Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infused Fc-tagged beta-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice.
    Grubb JH; Vogler C; Tan Y; Shah GN; MacRae AF; Sly WS
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8375-80. PubMed ID: 18544647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
    Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
    Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.
    O'Connor LH; Erway LC; Vogler CA; Sly WS; Nicholes A; Grubb J; Holmberg SW; Levy B; Sands MS
    J Clin Invest; 1998 Apr; 101(7):1394-400. PubMed ID: 9525982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS; Erway LC; Vogler C; Sly WS; Birkenmeier EH
    Blood; 1995 Sep; 86(5):2033-40. PubMed ID: 7655032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inner ear pathology in the mucopolysaccharidosis VII mouse.
    Ohlemiller KK; Hennig AK; Lett JM; Heidbreder AF; Sands MS
    Hear Res; 2002 Jul; 169(1-2):69-84. PubMed ID: 12121741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
    Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel GUSB mutation in Brazilian terriers with severe skeletal abnormalities defines the disease as mucopolysaccharidosis VII.
    Hytönen MK; Arumilli M; Lappalainen AK; Kallio H; Snellman M; Sainio K; Lohi H
    PLoS One; 2012; 7(7):e40281. PubMed ID: 22815736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.